Press release
Organoids Market Outlook: Analyzing Industry Trends, Growth Factors, and Forecasts for 2031
The Insight Partners is pleased to announce the release of its comprehensive report on the Global Organoids Market, providing a detailed survey of the current state of the industry. This report offers essential insights, including definitions, classifications, applications, and the industry chain structure.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00017616/?utm_source=OpenPR&utm_medium=10310
Key Highlights:
• Market Overview: A thorough analysis of the global Organoids market, including historical development, competitive landscape, and the status of major regions.
• Key Players: Notable companies profiled in the report include STEMCELL Technologies; Molecular Devices, LLC.; HUB Organoids B.V. (Hubrecht Organoid Technology); DefiniGEN; Organoid Therapeutics; Thermo Fisher Scientific Inc.; Corning Inc.; Merck KGaA; InSphero; ACRO Biosystems; and Bio-Techne Corporation
• Growth Strategies: The report highlights both organic and inorganic growth strategies employed by market players, such as product launches, acquisitions, partnerships, and collaborations.
Market Segmentation and Insights: The report includes a SWOT analysis of key companies, macro-economic indicators, and a detailed forecast based on various segments across five major regions: North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. Each region is further segmented by country and specific market segments.
Organoids Market Drivers and Opportunities
Surging Adoption of Personalized Medicine
The growing trend towards personalized medicine is significantly boosting the organoids market. Personalized medicine tailors treatment plans to individual patients based on their specific responses or disease risks. A report from the Personalized Medicine Coalition highlights that the share of personalized medicines among new FDA-approved molecular entities increased from 5% in 2005 to over 25% in 2016. In 2022, 12 out of 37 new molecular entities (approximately 34%) approved by the FDA were personalized medicines.
Furthermore, biopharmaceutical companies have ramped up their R&D investments in personalized drugs, with projections indicating a 33% increase by 2027. Research suggests a potential 69% growth in personalized medicine development in the coming years. The number of personalized medicines in the U.S. market also rose from 132 in 2016 to 286 in 2020, reflecting a robust demand that will further drive organoid applications in drug development.
Focus on Drug Discovery
The escalating need for innovative drugs is propelling drug discovery activities, thereby creating more opportunities for the organoids market. According to ClinicalTrials.gov, there were approximately 384,288 clinical trials registered in 2021. A survey by HUB indicates that organoids can help streamline drug discovery by identifying patients unlikely to benefit from certain treatments, potentially reducing clinical trial costs.
Organoids are versatile tools not only for cancer research but also for studying various diseases such as cystic fibrosis, polycystic kidney disease, and more. They can effectively mimic organ properties-structure and function-and restore the genetic state of tissues, making them valuable for gene editing and other therapeutic developments. As drug discovery continues to evolve, the demand for advanced technologies like organoid models will increase, presenting substantial growth opportunities for the market.
Get Full Copy of This Report: https://www.theinsightpartners.com/buy/TIPRE00017616/?utm_source=OpenPR&utm_medium=10310
For inquiries, please contact: Ankit Mathur
Phone: +1-646-491-9876
E-mail: sales@theinsightpartners.com
The Insight Partners is your one-stop research provider for actionable intelligence, specializing in various industries, including Healthcare, Technology, and Manufacturing.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00017616/?utm_source=OpenPR&utm_medium=10310
Key Highlights:
• Market Overview: A thorough analysis of the global Organoids market, including historical development, competitive landscape, and the status of major regions.
• Key Players: Notable companies profiled in the report include STEMCELL Technologies; Molecular Devices, LLC.; HUB Organoids B.V. (Hubrecht Organoid Technology); DefiniGEN; Organoid Therapeutics; Thermo Fisher Scientific Inc.; Corning Inc.; Merck KGaA; InSphero; ACRO Biosystems; and Bio-Techne Corporation
• Growth Strategies: The report highlights both organic and inorganic growth strategies employed by market players, such as product launches, acquisitions, partnerships, and collaborations.
Market Segmentation and Insights: The report includes a SWOT analysis of key companies, macro-economic indicators, and a detailed forecast based on various segments across five major regions: North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. Each region is further segmented by country and specific market segments.
Organoids Market Drivers and Opportunities
Surging Adoption of Personalized Medicine
The growing trend towards personalized medicine is significantly boosting the organoids market. Personalized medicine tailors treatment plans to individual patients based on their specific responses or disease risks. A report from the Personalized Medicine Coalition highlights that the share of personalized medicines among new FDA-approved molecular entities increased from 5% in 2005 to over 25% in 2016. In 2022, 12 out of 37 new molecular entities (approximately 34%) approved by the FDA were personalized medicines.
Furthermore, biopharmaceutical companies have ramped up their R&D investments in personalized drugs, with projections indicating a 33% increase by 2027. Research suggests a potential 69% growth in personalized medicine development in the coming years. The number of personalized medicines in the U.S. market also rose from 132 in 2016 to 286 in 2020, reflecting a robust demand that will further drive organoid applications in drug development.
Focus on Drug Discovery
The escalating need for innovative drugs is propelling drug discovery activities, thereby creating more opportunities for the organoids market. According to ClinicalTrials.gov, there were approximately 384,288 clinical trials registered in 2021. A survey by HUB indicates that organoids can help streamline drug discovery by identifying patients unlikely to benefit from certain treatments, potentially reducing clinical trial costs.
Organoids are versatile tools not only for cancer research but also for studying various diseases such as cystic fibrosis, polycystic kidney disease, and more. They can effectively mimic organ properties-structure and function-and restore the genetic state of tissues, making them valuable for gene editing and other therapeutic developments. As drug discovery continues to evolve, the demand for advanced technologies like organoid models will increase, presenting substantial growth opportunities for the market.
Get Full Copy of This Report: https://www.theinsightpartners.com/buy/TIPRE00017616/?utm_source=OpenPR&utm_medium=10310
For inquiries, please contact: Ankit Mathur
Phone: +1-646-491-9876
E-mail: sales@theinsightpartners.com
The Insight Partners is your one-stop research provider for actionable intelligence, specializing in various industries, including Healthcare, Technology, and Manufacturing.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
